Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
JNJ Technicals & Takeaways After Earnings, Healthcare Reaching Key Levels
04:00pm, Wednesday, 16'th Jul 2025
Johnson & Johnson (JNJ) shares popped after earnings that showed strength for the healthcare company. Rick Ducat dives into the stock chart to highlight how Johnson & Johnson is tapping a notable resi
Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript
03:36pm, Wednesday, 16'th Jul 2025
Johnson & Johnson (NYSE:JNJ ) Q2 2025 Earnings Conference Call July 16, 2025 8:30 AM ET Company Participants Darren Snellgrove - Corporate Participant Jennifer L. Taubert - Executive VP & Worldwide Ch
2 Dividend Giants Every Passive Income Investors Should Own
03:20pm, Wednesday, 16'th Jul 2025
It's never been easier as a passive income investor to give your yield a bit of a jolt with the rise of covered call (and premium income) ETFs that trade off a bit of upside potential for some premium
Johnson & Johnson Lifts 2025 Outlook
02:56pm, Wednesday, 16'th Jul 2025
Johnson & Johnson (JNJ 5.93%) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised full-
Why Johnson & Johnson Rallied Today
02:38pm, Wednesday, 16'th Jul 2025
Shares of Johnson & Johnson (JNJ 6.08%) rallied 6.1% on Wednesday as of 1:18 p.m. ET.
Johnson & Johnson Stock Jumps on Strong Earnings, Higher Outlook
02:10pm, Wednesday, 16'th Jul 2025
Johnson & Johnson (JNJ) shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook.
Johnson & Johnson Tops Q2 Estimates
02:10pm, Wednesday, 16'th Jul 2025
Johnson & Johnson (JNJ 5.57%), a global healthcare leader best known for its pharmaceutical, MedTech, and medical device portfolio, reported earnings for Q2 2025 on Wednesday, July 16, 2025, that topp
Final Trades: Johnson & Johnson, ICE and the IBIT
01:52pm, Wednesday, 16'th Jul 2025
The Investment Committee give you their stop stocks to watch for the second half.
Top Stock Movers Now: J&J, ASML, Tesla, and More
12:40pm, Wednesday, 16'th Jul 2025
Major U.S. equities indexes were little changed at midday Wednesday after a report on wholesale inflation showed a surprising slowdown in June.
PPI Remained Unchanged
12:21pm, Wednesday, 16'th Jul 2025
Pre-market futures are climbing into the green this morning, following a cooler-than-expected wholesale inflation report and better-than-expected financial Q2 earnings numbers out before the bell toda
JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise
11:55am, Wednesday, 16'th Jul 2025
JNJ tops second-quarter estimates and raises 2025 guidance as Innovative Medicines outperforms and MedTech gains momentum.
J&J CFO: We're pleased with the engagement with the Trump administration
11:30am, Wednesday, 16'th Jul 2025
Johnson & Johnson CFO Joseph Wolk said Wednesday that the company is pleased with its engagement with the Trump administration, especially around tax policy, crediting the 2017 tax cuts for driving J&
Cramer's Mad Dash: Johnson & Johnson
10:51am, Wednesday, 16'th Jul 2025
Jim Cramer breaks down why he's keeping an eye on shares of Johnson & Johnson.
Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say
10:31am, Wednesday, 16'th Jul 2025
The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street
Johnson & Johnson delivers earnings beat, raises full year sales and profit guidance
09:33am, Wednesday, 16'th Jul 2025
Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter and raised its full-year guidance. For Q2, revenue of $23.74 billion
